2017-003705-17: Hydrocortisone as co-treatment to prevent neuropsychiatric adverse effects of dexamethasone. Hydrocortison als co-medicatie om nadelige neuropsychiatrische effecten van dexamethason tegen te gaan. |
|
|
| Not yet recruiting | 4 | 180 | Europe | Tablet, Hydrocortison Tiofarma 20 mg, tabletten | LUMC, ZonMw | Neuropsychiatric adverse effects which can be caused by dexamethasone. For example delirium, anxiety, depression, mania and psychosis. But also cognitive impairment and sleep disturbance. Psychiatrische klachten die kunnen ontstaan bij dexamethason gebruik, zoals delier, angst, depressie, manie en psychoses. Ook cognitieve klachten en slaap klachten., Neuropsychiatric adverse effects which can be caused by dexamethasone. For example delirium, anxiety, depression, mania and psychosis. But also cognitive impairment and sleep disturbance. Psychiatrische klachten die kunnen ontstaan bij dexamethason gebruik, zoals delier, angst, depressie, manie en psychoses. Ook cognitieve klachten en slaap klachten., Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
| Withdrawn | 4 | 104 | US | Hydrocortisone, Cortef, Yohimbine, Yohimbine Hydrochloride, Placebo, Sugar pill | University of North Carolina, Chapel Hill | Borderline Personality Disorder | 07/25 | 07/25 | | |
| Recruiting | 2 | 220 | US, RoW | Placebo, Hydrocortisone, HCORT | Rachel Yehuda, James J. Peters Veterans Affairs Medical Center, The Chaim Sheba Medical Center | PTSD, Acute Stress Disorder, Trauma-related Stressor | 04/25 | 04/25 | | |
